RYTM insider transaction filings
RHYTHM PHARMACEUTICALS, INC. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-18. Screen RYTM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | Joshi Manher — Chief Medical Officer | Grant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | Garfield Alastair — Chief Scientific Officer | Sale (S): 2,007 @ $116.11 · Sale (S): 1,556 @ $117.08 · Sale (S): 3,400 @ $118.28 · Sale (S): 800 @ $119.17 | EDGAR |
| 2026-08-17 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 2,024 @ $6.80 · Sale (S): 5,079 @ $119.75 · Option exercise (M): 2,024 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Lee Jennifer Kayden — EVP, Head of North America | Option exercise (M): 35,000 @ $24.29 · Option exercise (M): 21,601 @ $6.80 · Sale (S): 75,834 @ $117.38 · Option exercise (M): 35,000 (derivative) @ $0 · Option exercise (M): 21,601 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Mazabraud Yann — EVP, Head of International | Option exercise (M): 46,625 @ $6.80 · Sale (S): 2,300 @ $111.80 · Sale (S): 1,000 @ $112.86 · Sale (S): 3,605 @ $114.70 · Sale (S): 14,568 @ $115.43 · Sale (S): 18,208 @ $116.49 · +2 more | EDGAR |
| 2026-07-02 | 4 | Garfield Alastair — Chief Scientific Officer | Option exercise (M): 4,445 · Tax withholding (F): 2,150 @ $110.41 · Option exercise (M): 4,445 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | TETRAULT LYNN A. — Director | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Arbuckle Stuart A — Director | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | JEAN CHRISTOPHE — Director | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | GOOD JENNIFER L — Director | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | MCGIRR DAVID W J — Director | Option exercise (M): 4,712 · Option exercise (M): 4,712 (derivative) @ $0 · Grant/award (A): 3,691 (derivative) @ $0 · Grant/award (A): 2,324 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | TETRAULT LYNN A. — Director | Option exercise (M): 37,000 @ $28.27 · Sale (S): 37,000 @ $100.32 · Option exercise (M): 37,000 (derivative) @ $0 | EDGAR |
| 2026-05-20 | 4 | Smith Hunter C — Chief Financial Officer | Option exercise (M): 3,000 @ $17.87 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | German Christopher Paul — Corporate Controller & CAO | Option exercise (M): 1,687 @ $56.69 · Option exercise (M): 1,349 @ $49.23 · Option exercise (M): 1,406 @ $17.97 · Sale (S): 4,643 @ $92.21 · Option exercise (M): 1,687 (derivative) @ $0 · Option exercise (M): 1,349 (derivative) @ $0 · +1 more | EDGAR |
| 2026-04-03 | 4 | Mazabraud Yann — EVP, Head of International | Option exercise (M): 12,875 · Option exercise (M): 10,375 (derivative) @ $0 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Popovits Kimberly J — Director | Grant/award (A): 6,808 (derivative) @ $0 · Grant/award (A): 10,257 (derivative) @ $0 | EDGAR |
| 2026-03-16 | 4 | Mathers Edward T — Director | Other (J): 4,199 @ $0 | EDGAR |
| 2026-03-06 | 4 | German Christopher Paul — Corporate Controller & CAO | Option exercise (M): 1,500 @ $17.97 · Sale (S): 5,614 @ $89.56 · Option exercise (M): 1,500 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Mazabraud Yann — EVP, Head of International | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Mathers Edward T — Director | Other (J): 4,198 @ $0 | EDGAR |
| 2026-03-03 | 4 | German Christopher Paul — Corporate Controller & CAO | Option exercise (M): 1,162 · Tax withholding (F): 342 @ $94.94 · Option exercise (M): 1,162 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Smith Hunter C — Chief Financial Officer | Option exercise (M): 6,099 @ $6.80 · Option exercise (M): 6,099 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | Smith Hunter C — Chief Financial Officer | Sale (S): 1,200 @ $99.42 · Sale (S): 200 @ $100.52 · Sale (S): 900 @ $101.70 · Sale (S): 1,069 @ $103.00 · Sale (S): 200 @ $103.84 · Sale (S): 1,308 @ $100.27 · +3 more | EDGAR |
| 2026-02-18 | 4 | Mazabraud Yann — EVP, Head of International | Option exercise (M): 10,000 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Shulman Joseph — Chief Technical Officer | Grant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Mazabraud Yann — EVP, Head of International | Grant/award (A): 23,350 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Lee Jennifer Kayden — EVP, Head of North America | Grant/award (A): 21,650 (derivative) @ $0 · Grant/award (A): 32,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Garfield Alastair — Chief Scientific Officer | Grant/award (A): 16,650 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Cramer Pamela J. — Chief Human Resources Officer | Grant/award (A): 11,650 (derivative) @ $0 · Grant/award (A): 17,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Meeker David P — President and CEO, Director | Grant/award (A): 71,900 (derivative) @ $0 · Grant/award (A): 107,850 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | German Christopher Paul — Corporate Controller & CAO | Grant/award (A): 5,215 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Smith Hunter C — Chief Financial Officer | Sale (S): 1,913 @ $102.66 · Sale (S): 700 @ $103.68 · Sale (S): 100 @ $104.76 · Sale (S): 2,266 @ $98.37 · Sale (S): 400 @ $99.44 · Sale (S): 100 @ $100.85 · +6 more | EDGAR |
| 2026-02-06 | 4 | Smith Hunter C — Chief Financial Officer | Sale (S): 1,500 @ $104.74 · Sale (S): 1,000 @ $106.60 · Sale (S): 747 @ $107.67 · Sale (S): 3,381 @ $106.06 | EDGAR |
| 2026-02-03 | 4 | Mazabraud Yann — EVP, Head of International | Option exercise (M): 5,500 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 16,968 · Tax withholding (F): 6,507 @ $108.99 · Option exercise (M): 2,656 (derivative) @ $0 · Option exercise (M): 3,937 (derivative) @ $0 · Option exercise (M): 4,125 (derivative) @ $0 · Option exercise (M): 6,250 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Lee Jennifer Kayden — EVP, Head of North America | Option exercise (M): 22,612 · Tax withholding (F): 9,237 @ $108.99 · Option exercise (M): 3,437 (derivative) @ $0 · Option exercise (M): 4,512 (derivative) @ $0 · Option exercise (M): 5,500 (derivative) @ $0 · Option exercise (M): 9,163 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Garfield Alastair — Chief Scientific Officer | Option exercise (M): 6,663 · Tax withholding (F): 2,026 @ $108.99 · Option exercise (M): 6,663 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Cramer Pamela J. — Chief Human Resources Officer | Option exercise (M): 13,293 · Tax withholding (F): 4,731 @ $108.99 · Option exercise (M): 2,343 (derivative) @ $0 · Option exercise (M): 2,650 (derivative) @ $0 · Option exercise (M): 3,300 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Smith Hunter C — Chief Financial Officer | Option exercise (M): 26,000 · Tax withholding (F): 10,750 @ $108.99 · Option exercise (M): 4,062 (derivative) @ $0 · Option exercise (M): 4,925 (derivative) @ $0 · Option exercise (M): 6,600 (derivative) @ $0 · Option exercise (M): 10,413 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Meeker David P — President and CEO, Director | Option exercise (M): 68,713 · Tax withholding (F): 31,522 @ $108.99 · Option exercise (M): 14,125 (derivative) @ $0 · Option exercise (M): 21,250 (derivative) @ $0 · Option exercise (M): 33,338 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | German Christopher Paul — Corporate Controller & CAO | Option exercise (M): 3,613 · Tax withholding (F): 1,138 @ $108.99 · Option exercise (M): 1,806 (derivative) @ $0 · Option exercise (M): 1,807 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Cramer Pamela J. — Chief Human Resources Officer | Option exercise (M): 3,350 @ $27.35 · Sale (S): 3,350 @ $111 · Option exercise (M): 3,350 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Cramer Pamela J. — Chief Human Resources Officer | Option exercise (M): 3,350 @ $27.35 · Sale (S): 3,350 @ $105 · Option exercise (M): 3,350 (derivative) @ $0 | EDGAR |
| 2025-11-12 | 4 | Cramer Pamela J. — Chief Human Resources Officer | Option exercise (M): 8,805 @ $19.02 · Option exercise (M): 10,546 @ $6.80 · Sale (S): 19,351 @ $98.82 · Option exercise (M): 3,515 @ $6.80 · Sale (S): 3,515 @ $100 · Option exercise (M): 8,805 (derivative) @ $0 · +2 more | EDGAR |
| 2025-11-03 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 9,748 @ $30.66 · Sale (S): 9,748 @ $115.24 · Option exercise (M): 9,748 (derivative) @ $0 | EDGAR |
| 2025-10-30 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 2,094 @ $27.35 · Option exercise (M): 721 @ $30.66 · Sale (S): 2,815 @ $115.01 · Option exercise (M): 2,094 (derivative) @ $0 · Option exercise (M): 721 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 2,093 @ $27.35 · Option exercise (M): 12,344 @ $30.66 · Sale (S): 2,693 @ $110.95 · Sale (S): 8,332 @ $112.06 · Sale (S): 3,412 @ $112.81 · Option exercise (M): 2,093 (derivative) @ $0 · +1 more | EDGAR |
| 2025-09-04 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 2,094 @ $27.35 · Option exercise (M): 14,687 @ $30.66 · Sale (S): 16,781 @ $105.30 · Option exercise (M): 2,094 (derivative) @ $0 · Option exercise (M): 14,687 (derivative) @ $0 | EDGAR |
| 2025-08-25 | 4 | Shulman Joseph — Chief Technical Officer | Option exercise (M): 4,188 @ $27.35 · Sale (S): 4,188 @ $100.07 · Option exercise (M): 4,188 (derivative) @ $0 | EDGAR |
| 2025-08-14 | 4 | Smith Hunter C — Chief Financial Officer | Option exercise (M): 24,611 @ $6.88 · Sale (S): 24,611 @ $96.33 · Option exercise (M): 3,477 @ $6.88 · Sale (S): 3,477 @ $96 · Option exercise (M): 24,611 (derivative) @ $0 · Option exercise (M): 3,477 (derivative) @ $0 | EDGAR |
Recent 8-K events — RHYTHM PHARMACEUTICALS, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-03 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-20 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RYTM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →